Almirall SA
MAD:ALM

Watchlist Manager
Almirall SA Logo
Almirall SA
MAD:ALM
Watchlist
Price: 8.47 EUR 2.11% Market Closed
Market Cap: 1.8B EUR
Have any thoughts about
Almirall SA?
Write Note

Almirall SA
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Almirall SA
Deferred Income Tax Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
Almirall SA
MAD:ALM
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Laboratorios Farmaceuticos ROVI SA
MAD:ROVI
Deferred Income Tax
€944k
CAGR 3-Years
9%
CAGR 5-Years
N/A
CAGR 10-Years
-8%
F
Faes Farma SA
MAD:FAE
Deferred Income Tax
€16.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
9%
Laboratorio Reig Jofre SA
MAD:RJF
Deferred Income Tax
€2.6m
CAGR 3-Years
-6%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
No Stocks Found

Almirall SA
Glance View

Market Cap
1.8B EUR
Industry
Pharmaceuticals

Almirall SA is a global biopharmaceutical company, which is focused on skin health. The company is headquartered in Barcelona, Barcelona and currently employs 1,785 full-time employees. The company went IPO on 2007-04-19. The firm focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The firm's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The firm operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.

ALM Intrinsic Value
11.31 EUR
Undervaluation 25%
Intrinsic Value
Price

See Also

Back to Top